
Conference Coverage
about 6 hours ago
Separating Cost From Cancer Pathways: Edward Arrowsmith, MD, MPHLatest Content

Coroner Reports Pennsylvania's Sixth Measles-Associated Death

Dyshidrotic Eczema Less Tied to Occupation Than Other Hand Eczema

FDA Approves First Treatment for BCG-Unresponsive Bladder Cancer

Historical Review Traces Scientific Progress in Sjögren Disease

Iberdomide Regimen Cuts RRMM Progression Risk by 51%, Trial Finds

Shorts










Center on Health Equity & Access
All News

Postpartum navigation missed its primary goal but raised postpartum visits and primary care use among Medicaid-insured patients.

Stigma, years-long diagnostic delays, and limited follow-up after a crisis remain hurdles for people with serious mental illness, experts say.

MedHaul’s platform streamlines nonemergency medical transportation, boosting on-time oncology visits, reducing costs, and helping patients reach critical care across underserved regions.

A 39,669-patient French cohort found ustekinumab and IL-23 inhibitors carry the lowest infection risk among biologics.

CMS' rule ending Medicaid and CHIP funding for pediatric sex-rejecting procedures is now in effect.

At a roundtable in Cleveland, kidney experts said IgA nephropathy and FSGS often go unrecognized, calling for EHR flags and better referral channels.

Labial gland biopsy may support diagnosis of neurologic Sjögren disease, especially when antibody tests are negative or inconclusive.

This analysis in RR MCL shows CAR T-cell therapy (brexucabtagene) yields higher complete responses vs bispecific antibodies; durability remains unclear.

Meta-analysis finds oral JAK inhibitors like baricitinib and ritlecitinib drive strong alopecia areata hair regrowth, improving SALT scores with manageable safety.

Follitropin delta yields cumulative ongoing pregnancy in 64.0% of patients under 35 and 43.9% of those 35 to 42 in 2 placebo-controlled IVF trials.



























